CRISPR

CRISPR1-hspe1

ID
ZDB-CRISPR-160128-31
Name
CRISPR1-hspe1
Previous Names
  • Z000042 (1)
Target
Sequence
5' - GGCAGGCTACCGTGGTAGCAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hg76 hspe1
hg77 hspe1
Expression
Gene expression in Wild Types + CRISPR1-hspe1
No data available
Phenotype
Phenotype resulting from CRISPR1-hspe1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-hspe1
Phenotype Fish Conditions Figures
whole organism decreased length, abnormal hspe1hg76/hg76 standard conditions Fig. 2 with image from Pei et al., 2018
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal hspe1hg76/hg76 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal hspe1hg76/hg76 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
swim bladder increased variability of size, abnormal hspe1hg76/hg76 standard conditions Fig. 2 with image from Pei et al., 2018
swim bladder uninflated, abnormal hspe1hg76/hg76 standard conditions Fig. 2 with image from Pei et al., 2018
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal hspe1hg77/hg77 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal hspe1hg77/hg77 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
whole organism decreased length, abnormal hspe1hg77/hg77 standard conditions Fig. 2 with image from Pei et al., 2018
swim bladder increased variability of size, abnormal hspe1hg77/hg77 standard conditions Fig. 2 with image from Pei et al., 2018
swim bladder uninflated, abnormal hspe1hg77/hg77 standard conditions Fig. 2 with image from Pei et al., 2018
liver decreased size, abnormal hspe1hg76/hg76; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver regeneration disrupted, abnormal hspe1hg76/hg76; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver regeneration disrupted, abnormal hspe1hg77/hg77; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver decreased size, abnormal hspe1hg77/hg77; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver decreased size, abnormal hspe1hg77/hg77; s931Tg/+ standard conditions Fig. S7 from Pei et al., 2018
Citations